Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/30974
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTesch G.H.en
dc.date.accessioned2021-05-14T10:28:29Zen
dc.date.available2021-05-14T10:28:29Zen
dc.date.copyright2010en
dc.date.created20100705en
dc.date.issued2012-10-12en
dc.identifier.citationSeminars in Nephrology. 30 (3) (pp 290-301), 2010. Date of Publication: May 2010.en
dc.identifier.issn0270-9295en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/30974en
dc.description.abstractEvidence from renal biopsies has shown that macrophage accumulation in diabetic kidneys predicts declining renal function, suggesting a pathogenic role for these cells in diabetic nephropathy. Further evidence from animal models has shown that macrophages are the major immune cells infiltrating the kidney in type 1 and type 2 diabetes, and that they contribute to the development of renal injury and sclerosis. This review examines macrophages in human and experimental diabetic nephropathy, exploring the mechanisms of macrophage recruitment and activation, and the process of macrophage-mediated injury in diabetic kidneys. The ability of current therapies and novel anti-inflammatory treatments to reduce macrophage-mediated injury in diabetic kidneys also is considered, which has important implications for the future management of patients with diabetic nephropathy. © 2010 Elsevier Inc.en
dc.languageenen
dc.languageEnglishen
dc.publisherW.B. Saunders (Independence Square West, Philadelphia PA 19106-3399, United States)en
dc.titleMacrophages and diabetic nephropathy.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.semnephrol.2010.03.007en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid20620673 [http://www.ncbi.nlm.nih.gov/pubmed/?term=20620673]en
dc.identifier.source359061175en
dc.identifier.institution(Tesch) Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC, Australiaen
dc.description.addressG.H. Tesch, Department of Nephrology, Monash Medical Centre, 246 Clayton Rd, Clayton, VIC 3168, Australia. E-mail: greg.tesch@med.monash.edu.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
dc.subect.keywordsChemokines Diabetic nephropathy Fibrosis Inflammation Macrophagesen
dc.identifier.authoremailTesch G.H.; greg.tesch@med.monash.edu.auen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeArticle-
item.cerifentitytypePublications-
Appears in Collections:Articles
Show simple item record

Page view(s)

8
checked on Nov 24, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.